NCT01902394

Brief Summary

The purpose of this study is to determine if substituting whole grains for refined grains in the diets of healthy adults over a period of 6 weeks alters the composition of the bacteria in the gut, and has beneficial effects on immune function, digestive health, cardiovascular health, regulation of body weight and composition, and vitamin K status. The investigators hypothesize that whole grain consumption over a period of 6 weeks will alter the gut microflora toward a more beneficial bacterial profile, improve the immune response while reducing oxidative stress and inflammatory markers, have favorable effects on factors influencing the regulation of body weight and composition,increase bacterial vitamin K synthesis, and beneficially effect surrogate markers of cholesterol synthesis/absorption, vitamin D concentrations, and whole genome DNA methylation patterns. In statin users it is hypothesized that, consumption of whole grains will alter statin pharmacokinetics by decreasing rate of statin absorption, resulting in more sustained plasma concentrations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2012

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

June 4, 2012

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

July 18, 2013

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

May 21, 2015

Status Verified

May 1, 2015

Enrollment Period

2.3 years

First QC Date

June 4, 2012

Last Update Submit

May 19, 2015

Conditions

Keywords

digestive health and natural defenses

Outcome Measures

Primary Outcomes (5)

  • change in T Cell-mediated immunity

    Delayed-type hypersensitivity (DTH) and lymphocyte proliferation will be measured at baseline (week 2 of washout period) and at week-6 of the diet intervention to assess adaptive immune function, specifically T cell-mediated immunity.

    week 2 of washout diet and week 6 of diet intervention

  • change in Lymphocyte proliferation

    Whole blood collected at baseline (week 2 of washout period) and at week-6 of the diet intervention will be investigated for the ability of lymphocytes to proliferate by quantifying the incorporation of tritium following mitogen stimulation.

    week 2 of washout diet and week 6 of diet intervention

  • change in Natural Killer Function

    The ability of peripheral blood mononuclear cells to bind and kill leukemia cells will be measured at baseline (week 2 of washout period) and at week-6 of the diet intervention

    week 2 of washout diet and week 6 of diet intervention

  • change in Cytokines

    Peripheral blood and stool samples will be analyzed at baseline (week 2 of washout diet) and week-6 of diet intervention for cytokines.

    week 2 of washout diet and week 6 of diet intervention

  • change in Salivary immunoglobulin A (IgA)

    Salivary IgA will be analyzed at baseline (week 2 of washout period) and at week-6 of the diet intervention.

    week 2 of washout diet and week 6 of intervention diet

Secondary Outcomes (20)

  • change in gut microbiota composition

    week 2 of washout diet and week 6 of intervention diet

  • change in cardiovascular health risk factors

    week 2 of washout diet and week 6 of intervention diet

  • change in vitamin K status

    week 2 of washout diet and week 6 of intervention diet

  • change in body composition

    week 2 of washout diet and week 6 of intervention diet

  • change in appetite

    Weekly for 8 weeks

  • +15 more secondary outcomes

Study Arms (3)

Whole grain rich diet

EXPERIMENTAL

Participants in the whole grain (WG) group will receive a diet providing 100% of energy requirements in a diet rich in whole grains.

Other: Whole grains

Refined grain rich diet

PLACEBO COMPARATOR

Participants in the refined grain (RG) group will receive a diet providing 100% of energy requirements in a diet rich in refined grains.

Other: Refined grains

Negative control

NO INTERVENTION

Subjects randomized to the negative control group will consume their own usual diet (i.e. not receive foods and beverages from the study).

Interventions

Following completion of the baseline period (a 2-week run-in phase), participants in the WG group will receive a diet providing 100% of energy requirements in a diet rich in whole grains and the RG group will be provided with 100% of energy requirements in a diet rich in refined grains but otherwise similar to the WG diet for 6 weeks.

Whole grain rich diet

Following completion of the baseline period (a 2-week run-in phase), participants in the WG group will receive a diet providing 100% of energy requirements in a diet rich in whole grains and the RG group will be provided with 100% of energy requirements in a diet rich in refined grains but otherwise similar to the WG diet for 6 weeks.

Refined grain rich diet

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy male and female subjects aged 40-65 y (women must be \> 1 year postmenopausal or had both ovaries removed, if premenopausal).
  • Body mass index (BMI) 20-35 kg/m.2
  • Pass screening blood and urine tests
  • Creatinine ≤ 1.5 mg/dL
  • glutamic oxaloacetic transaminase/serum glutamate pyruvate transaminase/total bilirubin ≤ twice the upper limit of normal range
  • Fasting glucose \<125 mg/dL
  • hematocrit ≥ 32%
  • white blood cell count ≥ 1.8 x 103/mm3 (M)
  • PLT ≥ 100 x 103/mm3 (thou/µL)
  • Must be willing to be randomized.
  • Those randomized to either the WG or RG groups must be willing to consume only study foods and beverages provided.

You may not qualify if:

  • Self reported weight change \>4kg within the past 3 months.
  • Have participated in a weight loss program within the last 3-months; eligible if in weight reduction program to maintain body weight.
  • Not willing to reduce habitual daily fiber intake (including prebiotics) within 2 wk prior to enrollment to \< \~7g/1000kcal/d for men, or \<\~8g/1000kcal/d for women if currently consuming greater amounts.
  • Not willing to stop consumption of probiotic or prebiotic supplements within 2 weeks prior to start of study if currently taking these, as well as during study participation.
  • Vegetarian diet.
  • Not willing to stop taking multivitamins, and supplements (with the exception of vitamin D and calcium), including fish oil or n-3 fatty acids and herbal supplements, for 30 days prior to or during study participation, if currently taking these.
  • Regular use of laxatives, stool softeners, or anti-diarrheal medications, and medications influencing food intake and/or appetite.
  • Not willing to undergo a 3-month washout period after colonoscopy prior to enrollment, and not willing to defer colonoscopy until after study completion.
  • Eating disorder within the past 10 years.
  • Disinhibited eating behavior as indicated by a score above 12 on the Three Factor Eating Questionnaire.
  • Food allergies or aversions or other issues with foods that would preclude use of study diets, including gluten, milk, nuts, or eggs.
  • Individuals identified during screening as having barriers expected to deter compliance with dietary requirements (e.g., stated dislike of study foods, inadequate resources to store and reheat meals, inability to adhere to food pick-up schedule).
  • Alcohol consumption \>2 drinks per day.
  • Not willing to abstain from alcohol consumption during the study.
  • Smoking or using nicotine containing products in the last 6 months.
  • +18 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

HNCRA at Tufts University

Boston, Massachusetts, 02111, United States

Location

Related Publications (3)

  • Karl JP, Meydani M, Barnett JB, Vanegas SM, Barger K, Fu X, Goldin B, Kane A, Rasmussen H, Vangay P, Knights D, Jonnalagadda SS, Saltzman E, Roberts SB, Meydani SN, Booth SL. Fecal concentrations of bacterially derived vitamin K forms are associated with gut microbiota composition but not plasma or fecal cytokine concentrations in healthy adults. Am J Clin Nutr. 2017 Oct;106(4):1052-1061. doi: 10.3945/ajcn.117.155424. Epub 2017 Aug 16.

  • Vanegas SM, Meydani M, Barnett JB, Goldin B, Kane A, Rasmussen H, Brown C, Vangay P, Knights D, Jonnalagadda S, Koecher K, Karl JP, Thomas M, Dolnikowski G, Li L, Saltzman E, Wu D, Meydani SN. Substituting whole grains for refined grains in a 6-wk randomized trial has a modest effect on gut microbiota and immune and inflammatory markers of healthy adults. Am J Clin Nutr. 2017 Mar;105(3):635-650. doi: 10.3945/ajcn.116.146928. Epub 2017 Feb 8.

  • Karl JP, Meydani M, Barnett JB, Vanegas SM, Goldin B, Kane A, Rasmussen H, Saltzman E, Vangay P, Knights D, Chen CO, Das SK, Jonnalagadda SS, Meydani SN, Roberts SB. Substituting whole grains for refined grains in a 6-wk randomized trial favorably affects energy-balance metrics in healthy men and postmenopausal women. Am J Clin Nutr. 2017 Mar;105(3):589-599. doi: 10.3945/ajcn.116.139683. Epub 2017 Feb 8.

MeSH Terms

Interventions

Whole Grains

Intervention Hierarchy (Ancestors)

Edible GrainCrops, AgriculturalFoodDiet, Food, and NutritionPhysiological PhenomenaSeedsFood and Beverages

Study Officials

  • Simin N Meydani, DVM, PhD

    Human Nutrition Research Center on Aging

    PRINCIPAL INVESTIGATOR
  • Junaidah B Barnett, MCH(N), PhD

    Human Nutrition Research Center on Aging

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts

Study Record Dates

First Submitted

June 4, 2012

First Posted

July 18, 2013

Study Start

June 1, 2012

Primary Completion

September 1, 2014

Study Completion

September 1, 2014

Last Updated

May 21, 2015

Record last verified: 2015-05

Locations